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CASE PRESENTATION
A 58-year-old woman with a past medical history of
hypertension and arthritis presented to the Emergency
Department of the Massachusetts General Hospital
complaining of 1 week of progressive fatigue. The patient
had visited her primary care physician 1 week before a
‘water pill refill’ and general medical examination. Results
of the examination were an elevated blood glucose level
and the diagnosis of diabetes mellitus. She was not
started on medication at that time, and was instructed to
return to the clinic in 1 week for follow-up. During the
ensuing week, she reported feeling increasingly tired and
depressed, to the point that she stopped eating and
drinking for approximately 4 days. Subsequently, she
developed mild right upper quadrant abdominal
discomfort, and noted that the color of her urine had
turned very dark. Her family became concerned about
her condition and decided to bring her to the hospital
for evaluation.
Other than hypertension and arthritis, her medical history
was unremarkable. She lived alone, smoked approximately
1 ½ packs of cigarettes a day, admitted to occasional alcohol
use, and was unemployed. Her only medications included
furosemide and ibuprofen, as needed for arthritis pain.
During her initial evaluation in the emergency depart-
ment, she denied any fever, chills, nausea, vomiting, dysuria,
or change in urinary frequency. Her blood pressure was
102/63 mmHg, heart rate 130–150 beats/min, temperature
97.4 F, respiratory rate 22 breaths/min, and she had an oxygen
saturation of 100% on 3 l O2 delivered via nasal prongs.
Her physical examination was notable for dry oral mucous
membranes, flat neck veins, clear lungs, tachycardia with an
irregularly irregular rhythm, obese abdomen with mild
tenderness to palpitation of her right upper quadrant and
right lower quadrant, and dry skin with slightly decreased
turgor. A foley catheter was placed and only 10 ml of dark
urine drained out. Her urine output did not increase after 6 l
of intravenous saline.
Initial laboratory data are shown in Table 1. In addition,
liver function tests were within normal limits. An examina-
tion of a peripheral blood smear showed no schistocytes. An
electrocardiogram was notable for atrial fibrillation. A chest
X-ray was unremarkable. An abdominal computer tomo-
graphy without contrast, revealed bilaterally enlarged kidneys
with extensive perinephric air collections surrounding both
kidneys as well as intraparenchymal air tracking down and
tracking down both ureters (Figure 1). A renal ultrasound
revealed enlarged heterogeneous kidneys with shadowing
punctuate echogenicities consistent with gas pockets but no
obstruction.
DIAGNOSIS
Acute anuric renal failure owing to bilateral emphysematous
pyelonephritis.
CLINICAL FOLLOW-UP
She was admitted to the surgical intensive care unit, and was
started on intravenous catecholamines for blood pressure
support as well as broad spectrum antibiotics. Blood and
urine cultures obtained on presentation to the Emergency
Department quickly grew out Escherichia coli. Urology
consultation was obtained, and it was decided not to proceed
with bilateral nephrectomy because of severe hemodynamic
instability. Instead, bilateral retrograde pyelouretograms were
performed, which revealed no evidence of ureteral obstruc-
tion. Owing to worsening acidemia and hyperkalemia,
continuous venovenous hemofiltration was initiated on
hospital day 2. Over the course of the next 2 days, her
hemodynamics gradually improved, and she was able to be
transitioned to intermittent hemodialysis on hospital day 4.
After being virtually anuric for the first week of hospitaliz-
ation, she started to make about 50–100 ml/day of cloudy
urine by day 8. A repeat non-contrast abdominal computer
tomography on day 11 showed worsening bilateral kidney
inflammation, for which bilateral percutaneous computer
tomography-guided drainage was attempted, but could
only drain 6 ml of pus from the left kidney. Nevertheless,
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she continued to steadily improve on antibiotics alone,
and was eventually transitioned to a general medical floor.
By the time she was discharged to a rehabilitation facility
on hospital day 20, she was making about 1500 ml of urine
a day, although she was still dialysis dependent owing to poor
clearance (her pre-dialysis creatinine level was 5.3 mg/dl
before discharge).
She was transferred back to hospital from the rehabilit-
ation facility 3 weeks later for evaluation of severe abdominal
pain. She was still requiring thrice weekly dialysis at this time.
Her initial evaluation revealed markedly distended loops
of both small and large bowel by abdominal computer
tomography, and she was conservatively treated with
intravenous fluids and observation. However, her condition
quickly deteriorated as she developed respiratory failure and
hypotension. After stabilization, she was taken to the
operating room for an exploratory laparotomy which
revealed a grossly distended colon consistent with toxic
megacolon (an assay for Clostridium difficile toxin in her
stool was positive the next day). She underwent a partial
colectomy, but remained critically ill and pressor-dependent
in the SICU. Owing to the severity of her illness and the
prospect of a long intensive care unit stay, her family decided
to withdraw care 5 days after admission. An autopsy was
refused by the family.
DISCUSSION
Gas-producing infections account for a very small percentage
of all bacterial infections of the urinary tract but they are
important to recognize because of their life-threatening
potential. The spectrum and differential diagnosis of gas-
producing infections include emphysematous pyelonephritis
(EPN), emphysematous pyelitis, and emphysematous cystitis.
These distinct clinical entities vary in clinical course,
management, and prognosis.1
EPN is a rare but life-threatening acute suppurative
infection of the kidney, characterized by production of gas
within the renal parenchyma, collecting system, or perinephric
tissues. One of the first case series of EPN was reported in 1898
by Kelly and MacCallum, who described a number of patients
suffering from gas in the urinary tract discovered either after
the urinary bladder became distended with gas, or after direct
observation of air bubbles emanating from the ureters during
cystoscopic examination. These cases were described as
‘pneumaturia’, and were found to be caused by gas-forming
bacterial infections of the kidney.2 Since then, there have been
more than 200 cases reported in the literature. In its most
severe forms, EPN can lead to septic shock and multiple organ
failure, with a mortality rate of up to 30% in several case series.
It occurs predominantly in diabetic patients (70–90%) and in
patients with urinary tract obstruction, and much more
commonly affects females than males by a 5–6:1 ratio. Less
than 10% of cases involve both kidneys.3–6
Table 1 | Laboratory values
Value (reference range)
Serum/Blood
Sodium 123 mmol/l (136–142)
Potassium 4.7 mmol/l (3.5–5.0)
Chloride 78 mmol/l (98–108)
Bicarbonate 17 mmol/l (23–32)
Glucose 487 mg/dl (54–118)
Urea nitrogen 138 mg/dl (9–25)
Creatinine 5.4 mg/dl
Calcium 8.8 mg/dl (8.8–10.5)
Phosphate 7.0 mg/dl (2.6–4.5)
Osmolarity 320 mosm/kg (278–297)
Total protein 5.1 g/dl (6.0–8.3)
Albumin 2.1 g/dl (3.7–5.4)
Direct bilirubin 0.5 mg/dl (0–0.4)
Total bilirubin 1.2 mg/dl (0.0–1.0)
Alkaline phosphatase 282 U/l (30–100)
SGPT 21 U/l (7–30)
SGOT 23 U/l (9–32)
Lactic dehydrogenase 739 U/l (110–210)
Acetone Trace
Hemoglobin A1c 10.5% (3.80–6.40)
CBC
White blood cells 17.3 th/cmm (4.5–11.0)
Neutrophils 80% (40–70)
Bands 14% (0–10)
Lymphocytes 3% (22–44)
Hematocrit 35.4% (36.0–46.0)
Platelets 27 th/cumm (150–350)
Urine
Urinalysis pH 5.5, specific gravity 1.25, 3+ blood,
3+ protein, 3+ ketone 3+ WBC. RBC4100,
few bacteria
Urine sediment Many RBCs, many WBCs, no cellular casts,
no dysmorphic RBC
RBC, red blod cell; WBC, white blood cell; SGPT, serum glutamic pyruvic trans-
aminase; SGOT, serum glutamic-oxaloacetic transaminase; th/cmm, thousands per
cubicmilimeter; th/cumm, thousands per cubicmilimeter.
Figure 1 | Computer tomography scan showing enlarged bilateral
kidneys with emphysematous changes within the renal
parenchyma.
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EPN is caused by glucose-fermenting bacteria, with over
90% of reported cases attributed to Escherichia coli, as in our
patient, and the rest attributed to a host of other microbes
such as Proteus mirabilis, Klebsiella pneumonia, Pseudomonas
aeruginosa, Bacteroides fragilis, Aerobacter aerogenes, Candida
albicans, and Crytococcus neoformans.7–10 Although the exact
pathogenesis of EPN is unclear, several studies implicate high
tissue concentrations of glucose, impaired tissue perfusion,
and defective or inadequate immune responses as important
contributors to the development of the disease.4,11,12
Supporting these associations is the fact that diabetes mellitus
with poor glycemic control and urinary tract obstruction,
is strong host factors that predispose to the development of
EPN. In addition, the hypoxic environment of kidney
medulla, especially in diabetic nephropathy with associated
microvascular disease, is thought to predispose these patients
to tissue ischemia and necrosis, thus potentiating the growth
of gas-forming microbes.11,12
Patients with EPN usually present with nonspecific signs
and symptoms such as fever, pain in the flanks, abdomen, or
back, nausea, changes in mental status, and even shock. More
unusual initial presentations of EPN include pneumo-
mediastinum and subcutaneous emphysema, or multiple
septic emboli to the brain, lungs, and liver.13,14
The diagnosis of EPN should be considered when sus-
pected cases of pyelonephritis do not respond to conven-
tional treatment, especially in diabetic patients with unstable
hemodynamics. As there are no signs or symptoms which are
pathognomonic of EPN, imaging data are essential in
distinguishing EPN from less severe cases of pyelonephritis.
Although plain abdominal films can show mottled gas in the
renal and perirenal space in about one-third of cases, a
computer tomography-scan of the abdomen is the preferred
diagnostic tool because it can define the extent and
quantification of the gas, and any destruction of the renal
parenchyma. Ultrasound is generally only useful for the
diagnosis of associated urinary tract obstruction.4,15,16
Optimum therapeutic strategies are ill-defined and con-
troversial owing to the rarity of cases and the associated lack
of well-designed randomized controlled studies. Although in
the past, nephrectomy and open drainage were considered
the first lines of therapy, these are currently only performed
in patients who fail medical management. Generally,
antibiotics, percutaneous drainage of abscesses, fluid resuscit-
ation, and tight control of glucose are the mainstays of
treatment. Successful treatment with medical management
alone has been reported even in the severe forms of bilateral
emphysematous pyelonephritis.11,17–27
Which of these modalities to pursue in individual cases
can be aided by classifying each case according to the degree
of severity of presentation. Huang and Tseng studied a
collection of 48 EPN patients from their institution and
classified the patients into four classes according to the
radiological findings as detailed in Table 2.8 The overall
mortality rate in this study was 18.7%, with higher classes
associated with higher mortality rates (up to 50% for class 4).
They identified thrombocytopenia, acute renal failure, altered
mental status, and sepsis as poor prognostic risk factors.
Based on the treatment and associated outcomes of these
patients, the authors proposed the following treatment
guidelines: (1) antibiotics and percutaneous drainage as the
initial treatment for all patients; (2) bilateral percutaneous
drainage for class 4 patients; (3) immediate nephrectomy for
class 3 patients with more than two risk factors; (4) nephre-
ctomy for all cases where percutaneous drainage fails.9 This
classification has been used by others as a guide for therapy
and prognosis.20,22
Although our patient had class 4 EPN and all the risk
factors associated with poor prognosis, emergent bilateral
nephrectomy was not attempted, given the substantial risks
associated with the procedure. As mentioned, an attempt at
percutaneous drainage of perinephric abscesses was unsuc-
cessful, but she did respond to antibiotic therapy to the point
that she was able to be discharged to rehab (though still
requiring hemodialysis). Unfortunately, she died of com-
plications from a prolonged hospitalization and broad-
spectrum antibiotic use causing C. difficile colitis.
In conclusion, EPN is a severe acute necrotizing pare-
nchymal renal infection caused by gas-forming bacteria. It
carries a much higher mortality than conventional cases of
pyelonephritis. It has no specific symptoms and signs, and
can be present in the absence of a septic physiology.
The diagnosis can only be made by radiological findings
underscoring the importance of abdominal computer tomo-
graphy-scan. EPN should be suspected in patients who are
not responding to therapy or patients with unexplained
abnormal gas formation in the body, especially in diabetic
patients with poor glycemic control. High-dose antibiotic
therapy alone or with percutaneous drainage in contrast to
bilateral nephrectomy may be a preferable approach to salvage
kidney function.
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